T1	Pharmacological_substance 0 9	Sirolimus
N1000 	Reference T1 MeSH:D020123	Sirolimus
T2	Pharmacological_substance 31 40	rapamycin
N1001 	Reference T2 MeSH:D020123	rapamycin
T3	Pharmacological_substance 188 197	Sirolimus
N1002 	Reference T3 MeSH:D020123	Sirolimus
T4	Pharmacological_substance 225 243	immunosuppressants
N1003 	Reference T4 MeSH:D007166	immunosuppressants
T5	Pharmacological_substance 336 345	sirolimus
N1004 	Reference T5 MeSH:D020123	sirolimus
T6	Pharmacological_substance 419 431	cyclosporine
N1005 	Reference T6 MeSH:D016572	cyclosporine
T7	Pharmacological_substance 435 445	tacrolimus
N1006 	Reference T7 MeSH:D016559	tacrolimus
T8	Pharmacological_substance 544 553	sirolimus
N1007 	Reference T8 MeSH:D020123	sirolimus
T9	Pharmacological_substance 575 587	cyclosporine
N1008 	Reference T9 MeSH:D016572	cyclosporine
T10	Pharmacological_substance 591 601	tacrolimus
N1009 	Reference T10 MeSH:D016559	tacrolimus
T11	Pharmacological_substance 696 708	cyclosporine
N1010 	Reference T11 MeSH:D016572	cyclosporine
T12	Pharmacological_substance 712 722	tacrolimus
N1011 	Reference T12 MeSH:D016559	tacrolimus
T13	Pharmacological_substance 88 105	immunosuppressive
N1012 	Reference T13 MeSH:D007166	immunosuppressive
T14	Disorder 169 186	adverse reactions
N1 	Reference T14 UMLS:C0559546	adverse reactions
T15	Pharmacological_substance 742 749	steroid
N1013 	Reference T15 MeSH:D013256	steroid
T16	Subject 11 20	mammalian
T19	Speculation_cue 134 137	can
T23	Combination 558 569	combination
T25	Speculation_cue 618 627	potential
T17	Disorder 655 673	rejection episodes
N2 	Reference T17 UMLS:C0011317	rejection episodes
